Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (IgG-Fv) (BSGV-160)

Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-FGF2 antibody variable domain is fused to the C terminal of an IgG of anti-VEGF antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.

Datasheet INQUIRY

Specifications

Targets

FGF2 & VEGF

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer

Targets

Target 1

FGF2

Gene ID

2247

UniProt ID

P09038

Alternative Names

FGF; Fibroblast growth factor; FGF2; fibroblast growth factor 2; BFGF; FGFB; FGF-2; HBGF-2

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (IgG-Fv) (BSGV-160). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (IgG-Fv) (CAT#: BSGV-160)

Specifications

Targets

Customer Reviews and Q&As